Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4644003019 | Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4644004013 | Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5302631000052116 | klavulansyra (som kaliumklavulanat) 100 mg/injektionsflaska och tikarcillin (som tikarcillindinatrium) 3 g/injektionsflaska, pulver till injektionsvätska | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Clavulanic acid and ticarcillin only product in parenteral dose form | true | Inferred relationship | Some | ||
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Ticarcillin disodium | true | Inferred relationship | Some | 1 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Ticarcillin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | g | true | Inferred relationship | Some | 1 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Clavulanate potassium (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Clavulanic acid (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets